124 related articles for article (PubMed ID: 38651500)
41. Cryptic chromosomal anomaly in a patient with acute myeloid leukemia leading to AML1/ETO fusion with unfavorable prognostic factors.
Ishii Y; Sashida G; Takaku TI; Sumi M; Nakajima A; Ohyashiki K
Cancer Genet Cytogenet; 2005 Jul; 160(1):94-5. PubMed ID: 15949579
[No Abstract] [Full Text] [Related]
42. Consistent detection of TLS/FUS-ERG chimeric transcripts in acute myeloid leukemia with t(16;21)(p11;q22) and identification of a novel transcript.
Kong XT; Ida K; Ichikawa H; Shimizu K; Ohki M; Maseki N; Kaneko Y; Sako M; Kobayashi Y; Tojou A; Miura I; Kakuda H; Funabiki T; Horibe K; Hamaguchi H; Akiyama Y; Bessho F; Yanagisawa M; Hayashi Y
Blood; 1997 Aug; 90(3):1192-9. PubMed ID: 9242552
[TBL] [Abstract][Full Text] [Related]
43. Clinical significance of galectin-3 in patients with adult acute myeloid leukemia: a retrospective cohort study with long-term follow-up and formulation of risk scoring system.
Gao N; Yu WZ; Guo NJ; Wang XX; Sun JR
Leuk Lymphoma; 2017 Jun; 58(6):1394-1402. PubMed ID: 27736291
[TBL] [Abstract][Full Text] [Related]
44. RNA sequencing as an alternative tool for detecting measurable residual disease in core-binding factor acute myeloid leukemia.
Kim T; Moon JH; Ahn JS; Ahn SY; Jung SH; Yang DH; Lee JJ; Shin MG; Choi SH; Lee JY; Tyndel MS; Lee HY; Kim KH; Cai Y; Lee YJ; Sohn SK; Min YH; Cheong JW; Kim HJ; Zhang Z; Kim DDH
Sci Rep; 2020 Nov; 10(1):20119. PubMed ID: 33208771
[TBL] [Abstract][Full Text] [Related]
45. CD66c (KOR-SA3544) antigen expression of leukemic blasts in pediatric acute myeloid leukemia with TLS/FUS-ERG fusion transcript.
Kobayashi K; Isobe K; Hanada R; Kawaguchi H; Iwata T; Kawamura M
Int J Lab Hematol; 2017 Dec; 39(6):e147-e150. PubMed ID: 28766906
[No Abstract] [Full Text] [Related]
46. ASXL2 mutation is recurrent in non-de novo AML1-ETO-negative acute myeloid leukemia.
Zhang X; Jin J; Yu W
Ann Hematol; 2019 Nov; 98(11):2621-2623. PubMed ID: 31637484
[No Abstract] [Full Text] [Related]
47. Measurable residual disease monitoring in acute myeloid leukemia with t(8;21)(q22;q22.1): results from the AML Study Group.
Rücker FG; Agrawal M; Corbacioglu A; Weber D; Kapp-Schwoerer S; Gaidzik VI; Jahn N; Schroeder T; Wattad M; Lübbert M; Koller E; Kindler T; Götze K; Ringhoffer M; Westermann J; Fiedler W; Horst HA; Greil R; Schroers R; Mayer K; Heinicke T; Krauter J; Schlenk RF; Thol F; Heuser M; Ganser A; Bullinger L; Paschka P; Döhner H; Döhner K
Blood; 2019 Nov; 134(19):1608-1618. PubMed ID: 31554635
[TBL] [Abstract][Full Text] [Related]
48. Co-expression of AML1-ETO and PML-RARa following treatment of de novo acute myeloid leukemia with AML1-ETO.
Zhang S; Zhou W; Li Y; Yu S; Xue M; Qiao Y; Jian J; Liu B; Wang D
Leuk Lymphoma; 2019 May; 60(5):1316-1319. PubMed ID: 30328750
[No Abstract] [Full Text] [Related]
49. RUNX1-MTG16 fusion gene in acute myeloblastic leukemia with t(16;21)(q24;q22): case report and review of the literature.
De Braekeleer E; Douet-Guilbert N; Le Bris MJ; Morel F; Férec C; De Braekeleer M
Cancer Genet Cytogenet; 2008 Aug; 185(1):47-50. PubMed ID: 18656694
[TBL] [Abstract][Full Text] [Related]
50. A novel HNRNPH1::ERG rearrangement in aggressive acute myeloid leukemia.
Jiang F; Lang X; Chen N; Jin L; Liu L; Wei X; Pan J; Yu F; Blake A; Xiao S
Genes Chromosomes Cancer; 2022 Aug; 61(8):503-508. PubMed ID: 35503261
[TBL] [Abstract][Full Text] [Related]
51. Quantitative PCR based minimal residual disease detection in core binding factor leukemias: prognostication and guiding of therapy.
Schnittger S; Schoch C
Leuk Res; 2006 Jun; 30(6):657-8. PubMed ID: 16386301
[No Abstract] [Full Text] [Related]
52. In rare acute myeloid leukemia patients harboring both RUNX1 and NPM1 mutations, RUNX1 mutations are unusual in structure and present in the germline.
Mendler JH; Maharry K; Becker H; Eisfeld AK; Senter L; Mrózek K; Kohlschmidt J; Metzeler KH; Schwind S; Whitman SP; Khalife J; Caligiuri MA; Klisovic RB; Moore JO; Carter TH; Marcucci G; Bloomfield CD
Haematologica; 2013 Aug; 98(8):e92-4. PubMed ID: 23753029
[No Abstract] [Full Text] [Related]
53. A novel RUNX1-C11orf41 fusion gene in a case of acute myeloid leukemia with a t(11;21)(p14;q22).
Abe A; Katsumi A; Kobayashi M; Okamoto A; Tokuda M; Kanie T; Yamamoto Y; Naoe T; Emi N
Cancer Genet; 2012 Nov; 205(11):608-11. PubMed ID: 23102734
[TBL] [Abstract][Full Text] [Related]
54. Significance of minimal residual disease monitoring by real-time quantitative polymerase chain reaction in core binding factor acute myeloid leukemia for transplantation outcomes.
Yalniz FF; Patel KP; Bashir Q; Marin D; Ahmed S; Alousi AM; Chen J; Ciurea SO; Rezvani K; Popat UR; Shpall EJ; Champlin RE; Oran B
Cancer; 2020 May; 126(10):2183-2192. PubMed ID: 32101640
[TBL] [Abstract][Full Text] [Related]
55. [Co-existence of AML1-ETO and BCR-ABL1 fusion genes in acute myeloid leukemia: a case report].
Yao YQ; Jia X; Liu H; Lu QS; Xiong WJ; Zhang Y; Liu QF; Shi PC
Zhonghua Nei Ke Za Zhi; 2024 Feb; 63(2):203-206. PubMed ID: 38326048
[TBL] [Abstract][Full Text] [Related]
56. Unusual type of TLS/FUS-ERG chimeric transcript in a pediatric acute myelocytic leukemia with 47,XX,+10,t(16;21)(p11;q22).
Choi HW; Shin MG; Sawyer JR; Cho D; Kee SJ; Baek HJ; Kook H; Kim HJ; Shin JH; Suh SP; Hwang TJ; Ryang DW
Cancer Genet Cytogenet; 2006 Jun; 167(2):172-6. PubMed ID: 16737920
[TBL] [Abstract][Full Text] [Related]
57. Allogeneic hematopoietic stem cell transplantation can improve the prognosis of high-risk pediatric t(8;21) acute myeloid leukemia in first remission based on MRD-guided treatment.
Hu GH; Cheng YF; Lu AD; Wang Y; Zuo YX; Yan CH; Wu J; Sun YQ; Suo P; Chen YH; Chen H; Jia YP; Liu KY; Han W; Xu LP; Zhang LP; Huang XJ
BMC Cancer; 2020 Jun; 20(1):553. PubMed ID: 32539815
[TBL] [Abstract][Full Text] [Related]
58. Establishment and characterization of a novel acute myeloid leukemia cell line, JIH-4, carrying a t(16;21)(p11.2;q22) and expressing the FUS-ERG fusion.
Jiang H; Qiu H; Xue Y; Pan J; Wu Y; Zhang J; Zheng J; Wang Q; Liang J; Chen S
Cancer Genet; 2011 Apr; 204(4):219-23. PubMed ID: 21536242
[TBL] [Abstract][Full Text] [Related]
59. Whole transcriptome sequencing of a paediatric case of de novo acute myeloid leukaemia with del(5q) reveals RUNX1-USP42 and PRDM16-SKI fusion transcripts.
Masetti R; Togni M; Astolfi A; Pigazzi M; Indio V; Rivalta B; Manara E; Rutella S; Basso G; Pession A; Locatelli F
Br J Haematol; 2014 Aug; 166(3):449-52. PubMed ID: 24673627
[No Abstract] [Full Text] [Related]
60. Minimal residual disease monitoring in t(8;21) acute myeloid leukemia based on RUNX1-RUNX1T1 fusion quantification on genomic DNA.
Duployez N; Nibourel O; Marceau-Renaut A; Willekens C; Helevaut N; Caillault A; Villenet C; Celli-Lebras K; Boissel N; Jourdan E; Dombret H; Figeac M; Preudhomme C; Renneville A
Am J Hematol; 2014 Jun; 89(6):610-5. PubMed ID: 24616160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
